Clinical • Trial completion date
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • PGR (Progesterone receptor) • PTEN (Phosphatase and tensin homolog)
|
HER-2 positive • EGFR mutation • PIK3CA mutation • PTEN-L
|
Herceptin (trastuzumab) • Perjeta (pertuzumab)